A detailed history of Commerzbank Aktiengesellschaft transactions in Eli Lilly & CO stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 6,225 shares of LLY stock, worth $4.96 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,225
Previous 4,254 46.33%
Holding current value
$4.96 Million
Previous $3.85 Million 43.21%
% of portfolio
0.15%
Previous 0.13%

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $1.52 Million - $1.89 Million
1,971 Added 46.33%
6,225 $5.52 Million
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $281,974 - $353,616
389 Added 10.06%
4,254 $3.85 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $567,919 - $759,796
959 Added 33.0%
3,865 $3.01 Million
Q4 2023

Sep 30, 2024

SELL
$525.19 - $619.13 $707,956 - $834,587
-1,348 Reduced 31.69%
2,906 $1.69 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $854,484 - $1.01 Million
1,627 Added 127.21%
2,906 $1.69 Million
Q3 2023

Sep 30, 2024

SELL
$434.7 - $599.3 $1.29 Million - $1.78 Million
-2,975 Reduced 69.93%
1,279 $687,000
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $555,981 - $766,504
1,279 New
1,279 $687,000
Q2 2023

Oct 01, 2024

SELL
$350.74 - $468.98 $1.17 Million - $1.57 Million
-3,345 Reduced 78.63%
909 $426,000
Q2 2023

Sep 30, 2024

SELL
$350.74 - $468.98 $1.17 Million - $1.57 Million
-3,345 Reduced 78.63%
909 $426,000
Q1 2023

Oct 02, 2024

SELL
$310.63 - $364.82 $1.1 Million - $1.3 Million
-3,554 Reduced 83.54%
700 $240,000
Q1 2023

Sep 30, 2024

SELL
$310.63 - $364.82 $1.1 Million - $1.3 Million
-3,554 Reduced 83.54%
700 $240,000
Q4 2022

Oct 02, 2024

BUY
$321.55 - $374.67 $2.97 Million - $3.46 Million
9,236 Added 217.11%
13,490 $4.94 Million
Q4 2022

Sep 30, 2024

BUY
$321.55 - $374.67 $2.97 Million - $3.46 Million
9,236 Added 217.11%
13,490 $4.94 Million
Q3 2022

Oct 02, 2024

BUY
$296.48 - $337.87 $2.81 Million - $3.21 Million
9,486 Added 222.99%
13,740 $4.44 Million
Q3 2022

Sep 30, 2024

BUY
$296.48 - $337.87 $2.81 Million - $3.21 Million
9,486 Added 222.99%
13,740 $4.44 Million
Q2 2022

Oct 02, 2024

BUY
$278.73 - $327.27 $2.09 Million - $2.45 Million
7,486 Added 175.98%
11,740 $3.81 Million
Q2 2022

Oct 01, 2024

BUY
$278.73 - $327.27 $2.09 Million - $2.45 Million
7,486 Added 175.98%
11,740 $3.81 Million
Q1 2022

Oct 02, 2024

BUY
$234.69 - $291.66 $826,343 - $1.03 Million
3,521 Added 82.77%
7,775 $2.23 Million
Q1 2022

Oct 01, 2024

BUY
$234.69 - $291.66 $826,343 - $1.03 Million
3,521 Added 82.77%
7,775 $2.23 Million
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $1.74 Million - $2.17 Million
-7,425 Closed
0 $0
Q4 2021

Oct 02, 2024

BUY
$224.85 - $279.04 $712,999 - $884,835
3,171 Added 74.54%
7,425 $2.05 Million
Q4 2021

Oct 01, 2024

BUY
$224.85 - $279.04 $712,999 - $884,835
3,171 Added 74.54%
7,425 $2.05 Million
Q4 2021

Jan 24, 2022

BUY
$224.85 - $279.04 $1.67 Million - $2.07 Million
7,425 New
7,425 $2.05 Million
Q3 2021

Oct 01, 2024

BUY
$221.6 - $272.71 $580,813 - $714,772
2,621 Added 61.61%
6,875 $1.59 Million
Q2 2021

Oct 02, 2024

SELL
$180.55 - $233.54 $564,940 - $730,746
-3,129 Reduced 73.55%
1,125 $258,000
Q1 2021

Oct 02, 2024

SELL
$164.32 - $212.72 $514,157 - $665,600
-3,129 Reduced 73.55%
1,125 $210,000
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $620,165 - $746,362
-4,546 Closed
0 $0
Q1 2020

Oct 03, 2024

BUY
$119.05 - $147.35 $34,762 - $43,026
292 Added 6.86%
4,546 $631,000
Q1 2020

Apr 29, 2020

SELL
$119.05 - $147.35 $2.1 Million - $2.6 Million
-17,644 Reduced 79.51%
4,546 $631,000
Q4 2019

Oct 03, 2024

BUY
$106.92 - $132.43 $1.92 Million - $2.38 Million
17,936 Added 421.63%
22,190 $2.92 Million
Q4 2019

Jan 17, 2020

SELL
$106.92 - $132.43 $6.45 Million - $7.99 Million
-60,327 Reduced 73.11%
22,190 $2.92 Million
Q3 2019

Oct 03, 2024

BUY
$106.79 - $116.16 $8.36 Million - $9.09 Million
78,263 Added 1839.75%
82,517 $9.23 Million
Q3 2019

Oct 17, 2019

SELL
$106.79 - $116.16 $13,348 - $14,520
-125 Reduced 0.15%
82,517 $9.23 Million
Q2 2019

Oct 03, 2024

BUY
$110.79 - $129.32 $8.73 Million - $10.2 Million
78,788 Added 1852.09%
83,042 $9.2 Million
Q2 2019

Jul 23, 2019

SELL
$110.79 - $129.32 $130,399 - $152,209
-1,177 Reduced 1.4%
82,642 $9.16 Million
Q1 2019

Oct 03, 2024

BUY
$111.31 - $131.02 $8.91 Million - $10.5 Million
80,056 Added 1881.9%
84,310 $10.9 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $284,953 - $335,411
-2,560 Reduced 2.96%
83,819 $10.9 Million
Q4 2018

Oct 03, 2024

BUY
$105.9 - $118.64 $8.7 Million - $9.74 Million
82,125 Added 1930.54%
86,379 $10 Million
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $1.52 Million - $1.7 Million
-14,345 Reduced 14.24%
86,379 $10 Million
Q3 2018

Oct 04, 2024

BUY
$85.86 - $107.31 $8.32 Million - $10.4 Million
96,870 Added 2277.15%
101,124 $10.9 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $474,548 - $593,102
-5,527 Reduced 5.2%
100,724 $10.8 Million
Q2 2018

Oct 04, 2024

BUY
$75.7 - $86.88 $7.75 Million - $8.9 Million
102,397 Added 2407.08%
106,651 $9.1 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $1.79 Million - $2.06 Million
-23,711 Reduced 18.24%
106,251 $9.07 Million
Q1 2018

Oct 04, 2024

BUY
$74.21 - $87.6 $1.64 Million - $1.93 Million
22,035 Added 20.34%
130,362 $10.1 Million
Q1 2018

May 01, 2018

BUY
$74.21 - $87.6 $1.64 Million - $1.93 Million
22,035 Added 20.42%
129,962 $10.1 Million
Q4 2017

Oct 04, 2024

BUY
$81.94 - $87.89 $8.53 Million - $9.15 Million
104,073 Added 2446.47%
108,327 $9.15 Million
Q4 2017

Jan 26, 2018

SELL
$81.94 - $87.89 $307,520 - $329,851
-3,753 Reduced 3.36%
107,927 $9.12 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $547,659 - $607,847
7,106 Added 6.8%
111,680 $9.55 Million
Q2 2017

Aug 09, 2017

BUY
N/A
104,574
104,574 $8.61 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.